SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009687
Filing Date
2022-05-12
Accepted
2022-05-12 16:21:35
Documents
58
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q clsd-20220331.htm   iXBRL 10-Q 1270685
2 EX-31.1 clsd-ex31_1.htm EX-31.1 17724
3 EX-31.2 clsd-ex31_2.htm EX-31.2 17378
4 EX-32.1 clsd-ex32_1.htm EX-32.1 11793
5 GRAPHIC img140551570_0.jpg GRAPHIC 117355
  Complete submission text file 0000950170-22-009687.txt   5295431

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clsd-20220331_lab.xml EX-101.LAB 351531
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clsd-20220331_pre.xml EX-101.PRE 254116
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clsd-20220331.xsd EX-101.SCH 41448
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT clsd-20220331_def.xml EX-101.DEF 146359
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT clsd-20220331_cal.xml EX-101.CAL 30407
52 EXTRACTED XBRL INSTANCE DOCUMENT clsd-20220331_htm.xml XML 777179
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37783 | Film No.: 22918141
SIC: 2834 Pharmaceutical Preparations